H1N1 pneumonitis treated with intravenous zanamivir.
Kidd
I Michael
IM
Department of Virology, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK. Electronic address: Michael.Kidd@uclh.nhs.uk.
Down
Jim
J
Department of Critical Care, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.
Nastouli
Eleni
E
Department of Virology, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.
Shulman
Rob
R
Department of Critical Care, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.
Grant
Paul R
PR
Department of Virology, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.
Howell
David Cj
DC
Department of Critical Care, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.
Singer
Mervyn
M
Department of Critical Care, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.
D000280:Administration, Inhalation; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001992:Bronchoalveolar Lavage Fluid / Q000821:virology; D003422:Critical Care / Q000379:methods; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D053118:Influenza A Virus, H1N1 Subtype; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000627:therapeutic use; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D011024:Pneumonia, Viral / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D016896:Treatment Outcome; D019562:Viral Load; D053243:Zanamivir / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D053243:Zanamivir; D008775:Methylprednisolone